Mednet Logo

Do you prioritize adding a GLP-1 receptor agonist over an SGLT-2 inhibitor in patients with CKD related to type 2 diabetes, uncontrolled proteinuria despite being on an ACEi, and obesity?

Community PollStarted

Do you prioritize adding a GLP-1 receptor agonist over an SGLT-2 inhibitor in patients with CKD related to type 2 diabetes, uncontrolled proteinuria despite being on an ACEi, and obesity?

54 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet MemberInvited Expert
Nephrology · Penn Medicine Cherry Hill
Answered on

My habit to date has been to use an SGLT-2 inhibitor first. I refer patients to PCPs or others for GLP-1 treatment for obesity, even if they have CKD.

Join for free or sign in to see the full answer